Delivery Order SPE2DR25D3101-SPE2DR26F5M57
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,446.64 to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of May 9, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under the company's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,247.90 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on July 16, 2025, with completion scheduled for July 17, 2025. This competitive, non-set-aside delivery order represents a firm fixed-price transaction for pharmaceutical supply. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units) with a ceiling value of $5,859.08. This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, represents a competitive award with no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,404.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This firm fixed-price, competitively awarded delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $70,061.60 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, where the products will...
- The Defense Logistics Agency (DLA) awarded a $1,589.62 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count package). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) with a ceiling value of $14,675.36. This firm fixed-price delivery order, awarded on June 30, 2025, with a completion date of July 1, 2025, represents a competitive procurement with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,437.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units). The award, issued on October 24, 2025, with an ultimate completion date of October 27, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive selection. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,419.07 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on August 1, 2025. This firm fixed-price delivery order, which is part of a non-set-aside competitive procurement, is scheduled for completion by August 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of NURTEC ODT 75 mg tablets (8 count). This is a firm fixed price delivery order with a ceiling value of $11,327.55 and an ultimate completion date of November 4, 2025. The award was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5M57Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) with a ceiling value of $5,850.24. This competitively awarded, non-set-aside contract employs firm fixed pricing and is scheduled for ultimate completion on November 17, 2025. The order will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor serving the federal government, AmerisourceBergen supplies a broad portfolio of medications and medical commodities to support military healthcare systems and other government agencies. The company's extensive federal contracting history demonstrates its capability to deliver specialized pharmaceuticals, including neurological and pain management medications, through a flexible contract structure designed to meet diverse military and veteran healthcare procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 11/14/25 |